Scientists test Next-Gen mRNA flu shot in first human trial
NCT ID NCT05755620
Summary
This early-stage study tested a new mRNA-based flu vaccine in healthy adults to see if it's safe and triggers a good immune response. Researchers gave 50 volunteers different doses of the experimental vaccine or a standard flu shot for comparison. The main goal was to check for side effects and measure how well the body produced antibodies against the flu.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke Vaccine and Trials Unit
Durham, North Carolina, 27704, United States
Conditions
Explore the condition pages connected to this study.